TTAAV Biomanufacturing Solutions
TAAV Biomanufacturing Solutions is a contract development and manufacturing organization (CDMO) in San Sebastián, Spain that produces neDNA™ (enzymatic, synthetic linear closed-ended DNA, formerly marketed as dbDNA), a fast alternative to plasmid DNA as critical starting material for AAV-based gene therapies. It was created around 2018-2019 as a joint venture between AskBio and UK-based Touchlight Genetics, whose amplification technology it licenses; AskBio took 100% ownership in early 2022, making TAAV a wholly owned subsidiary of AskBio and therefore of Bayer AG.
SectorsBiotech, Gene Therapy, CDMO / Biomanufacturing, Life Sciences, Synthetic DNA
Start-up MapHealthtech & Bio › Biologics manufacturing & CDMO
Founders
No names on record yet.
Global models 5
RResilience
United States · resilience.com ↗
Venture-backed CDMO that manufactures biologics, including gene-therapy materials, for drug developers on contract.
$2B+Comparable
CCenter for Breakthrough Medicines
United States · cbm.com ↗
Contract manufacturer of plasmid DNA and viral vectors for cell and gene therapy developers, the same B2B supply model as TAAV.
$1.1BComparable
TTouchlight
United Kingdom · www.touchlight.com ↗
Makes enzymatic doggybone DNA (dbDNA) and supplies it to gene-therapy and genetic-medicine makers as a CDMO-style starting-material provider; it is the technology licensor behind TAAV.
~$150MComparable
AAnsa Biotechnologies
United States · ansabio.com ↗
Makes enzymatically synthesised DNA and sells it as a service to biotech and pharma customers, replacing traditional DNA supply.
~$120MComparable
EElegen
United States · www.elegenbio.com ↗
Cell-free, synthetic long-DNA manufacturer that sells ready-made DNA to therapeutics developers as an alternative to plasmid-based production.
~$45MComparable
In the same niche 8 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 1
Open as list →
Funding rounds
No announced rounds on record.
News
No coverage on record yet.